Company news

Dimerix Limited news in 2018

Dimerix Limited's news releases, calls and decks from 2018, newest first.

View company

Dimerix Receives R&D Tax Cash Rebate Totalling $1.07m

December 19, 2018

1st Patient Dosed in DMX-200 Clinical Trial for FSGS

November 21, 2018

DXB Receives Orphan Drug Designation in EU

November 20, 2018

First patient dosed in dmx-200 clinical trial

November 19, 2018

Executive team bolstered through CEO & md appointment

August 26, 2018

Quarterly Review & Appendix 4C

July 31, 2018

Ethics Approval Received Appendix 3B and S.708A Notice

July 18, 2018

Further US patent allowed for DMX-200

July 1, 2018

Dual Phase 2 trials launched for CKD

May 14, 2018

Westar Capital Retained as Corporate Advisors

April 12, 2018

CMO Appointment and Clinical Trials Update

March 26, 2018

Half Year Report and Financial Statements

February 26, 2018

Oversubscribed Placement to Raise a Further $4.5m

February 20, 2018

Quarterly Review and Appendix 4C

January 29, 2018

Results of Entitlement Offer

January 23, 2018

DMX-200 Dosage Optimisation Study Successfully Completed

January 7, 2018

Decks in 2018